Literature DB >> 25398982

Hypertension overrides the protective effect of female hormones on the development of aortic aneurysm secondary to Alk5 deficiency via ERK activation.

Bradley M Schmit1, Pu Yang1, Chunhua Fu1, Kenneth DeSart1, Scott A Berceli2, Zhihua Jiang3.   

Abstract

The prevalence of aortic aneurysm is five times higher in men than women among the general population. Similar sexual dimorphism also exists in syndromic aortic aneurysms triggered by TGF-β signaling disorders. To understand the responsible mechanisms, we developed an animal model where inducible deletion of the type I TGF-β receptor, Alk5, specifically in smooth muscle cells (Alk5iko) causes spontaneous aortic aneurysm formation. This model recapitulated an extreme scenario of the dimorphism in aortic aneurysm development between genders. In a comparative experiment, all Alk5iko males (n=42) developed aortic aneurysms and 26% of them died prematurely from aortic rupture. In contrast, the Alk5iko females (n=14) presented only a subclinical phenotype characteristic of scarcely scattered elastin breaks. Removal of male hormones via orchiectomy (n=7) resulted in only minimal influence on aortic pathology. However, reduction of female hormones via ovariectomy (n=15) increased the phenotypic penetrance from zero to 53%. Finally, an elevation of systolic blood pressure by 30 points unmasked the subclinical phenotype of Alk5iko females (n=17) to 59%. This exaggerated phenotypic penetrance was coupled with an early intensification of ERK signaling, a molecular signature that correlated to 100% phenotypic penetrance in normotensive Alk5iko males. In conclusion, aortic aneurysm induced by Alk5iko exhibits dimorphic incidence between genders with females less susceptible to aortic disease. This sexual dimorphism is partially the result from the protective effects of female hormones. Hypertension, a known risk factor for aortic aneurysm, is able to break the female sex protective effects through mechanisms associated with enhanced ERK activity.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  TGF-β; aortic aneurysm; sexual dimorphism

Mesh:

Substances:

Year:  2014        PMID: 25398982      PMCID: PMC4338934          DOI: 10.1152/ajpheart.00521.2014

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  46 in total

Review 1.  The MEK/ERK cascade: from signaling specificity to diverse functions.

Authors:  Yoav D Shaul; Rony Seger
Journal:  Biochim Biophys Acta       Date:  2006-10-19

2.  Hypertension accelerated experimental abdominal aortic aneurysm through upregulation of nuclear factor kappaB and Ets.

Authors:  Suguru Shiraya; Ken Miwa; Motokuni Aoki; Takashi Miyake; Masako Oishi; Kazusaburo Kataoka; Shigetsugu Ohgi; Toshio Ogihara; Yasufumi Kaneda; Ryuichi Morishita
Journal:  Hypertension       Date:  2006-08-28       Impact factor: 10.190

3.  Quantifying the risks of hypertension, age, sex and smoking in patients with abdominal aortic aneurysm.

Authors:  K A Vardulaki; N M Walker; N E Day; S W Duffy; H A Ashton; R A Scott
Journal:  Br J Surg       Date:  2000-02       Impact factor: 6.939

4.  Androgen increases AT1a receptor expression in abdominal aortas to promote angiotensin II-induced AAAs in apolipoprotein E-deficient mice.

Authors:  Tracy Henriques; Xuan Zhang; Frederique B Yiannikouris; Alan Daugherty; Lisa A Cassis
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-05-01       Impact factor: 8.311

5.  Angiotensin II blockade and aortic-root dilation in Marfan's syndrome.

Authors:  Benjamin S Brooke; Jennifer P Habashi; Daniel P Judge; Nishant Patel; Bart Loeys; Harry C Dietz
Journal:  N Engl J Med       Date:  2008-06-26       Impact factor: 91.245

6.  ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2.

Authors:  Sung O Park; Young Jae Lee; Tsugio Seki; Kwon-Ho Hong; Naime Fliess; Zhigang Jiang; Alice Park; Xiaofang Wu; Vesa Kaartinen; Beth L Roman; S Paul Oh
Journal:  Blood       Date:  2007-10-02       Impact factor: 22.113

7.  Traditional and novel risk factors for clinically diagnosed abdominal aortic aneurysm: the Kaiser multiphasic health checkup cohort study.

Authors:  Carlos Iribarren; Jeanne A Darbinian; Alan S Go; Bruce H Fireman; Chong D Lee; Douglas P Grey
Journal:  Ann Epidemiol       Date:  2007-05-18       Impact factor: 3.797

8.  Risk factors for abdominal aortic aneurysms: a 7-year prospective study: the Tromsø Study, 1994-2001.

Authors:  Signe Helene Forsdahl; Kulbir Singh; Steinar Solberg; Bjarne K Jacobsen
Journal:  Circulation       Date:  2009-04-13       Impact factor: 29.690

9.  Abdominal aortic aneurysm: the prognosis in women is worse than in men.

Authors:  P E Norman; J T Powell
Journal:  Circulation       Date:  2007-06-05       Impact factor: 29.690

Review 10.  Sex-specific genetic architecture of human disease.

Authors:  Carole Ober; Dagan A Loisel; Yoav Gilad
Journal:  Nat Rev Genet       Date:  2008-12       Impact factor: 53.242

View more
  11 in total

1.  An X-linked Myh11-CreERT2 mouse line resulting from Y to X chromosome-translocation of the Cre allele.

Authors:  Mingmei Liao; Junmei Zhou; Fen Wang; Yasmin H Ali; Kelvin L Chan; Fei Zou; Stefan Offermanns; Zhisheng Jiang; Zhihua Jiang
Journal:  Genesis       Date:  2017-09       Impact factor: 2.487

2.  Second Heart Field-Derived Cells Contribute to Angiotensin II-Mediated Ascending Aortopathies.

Authors:  Hisashi Sawada; Yuriko Katsumata; Hideyuki Higashi; Chen Zhang; Yanming Li; Stephanie Morgan; Lang H Lee; Sasha A Singh; Jeff Z Chen; Michael K Franklin; Jessica J Moorleghen; Deborah A Howatt; Debra L Rateri; Ying H Shen; Scott A LeMaire; Masanori Aikawa; Mark W Majesky; Hong S Lu; Alan Daugherty
Journal:  Circulation       Date:  2022-02-10       Impact factor: 29.690

3.  Cyclophilin A contributes to aortopathy induced by postnatal loss of smooth muscle TGFBR1.

Authors:  Guannan Zhou; Mingmei Liao; Fen Wang; Xiaoyan Qi; Pu Yang; Scott A Berceli; Ashish K Sharma; Gilbert R Upchurch; Zhihua Jiang
Journal:  FASEB J       Date:  2019-07-16       Impact factor: 5.834

4.  Smooth muscle cell-specific Tgfbr1 deficiency promotes aortic aneurysm formation by stimulating multiple signaling events.

Authors:  Pu Yang; Bradley M Schmit; Chunhua Fu; Kenneth DeSart; S Paul Oh; Scott A Berceli; Zhihua Jiang
Journal:  Sci Rep       Date:  2016-10-14       Impact factor: 4.379

5.  Sex, pregnancy and aortic disease in Marfan syndrome.

Authors:  Marjolijn Renard; Laura Muiño-Mosquera; Elise C Manalo; Sara Tufa; Eric J Carlson; Douglas R Keene; Julie De Backer; Lynn Y Sakai
Journal:  PLoS One       Date:  2017-07-14       Impact factor: 3.240

6.  Smooth muscle cell-specific Tgfbr1 deficiency attenuates neointimal hyperplasia but promotes an undesired vascular phenotype for injured arteries.

Authors:  Mingmei Liao; Pu Yang; Fen Wang; Scott A Berceli; Yasmin H Ali; Kelvin L Chan; Zhihua Jiang
Journal:  Physiol Rep       Date:  2016-12

7.  Heterogeneity of Aortic Smooth Muscle Cells: A Determinant for Regional Characteristics of Thoracic Aortic Aneurysms?

Authors:  Hisashi Sawada; Jeff Z Chen; Bradley C Wright; Mary B Sheppard; Hong S Lu; Alan Daugherty
Journal:  J Transl Int Med       Date:  2018-10-09

8.  Nicotine Exacerbates TAAD Formation Induced by Smooth Muscle-Specific Deletion of the TGF-β Receptor 2.

Authors:  Changzoon Chun; Xiaoyan Qi; Fen Wang; Kyle B Madrid; Lennon A Saldarriaga; Max R Fisch; Mark L Brantly; Gilbert R Upchurch; Zhihua Jiang
Journal:  J Immunol Res       Date:  2021-10-01       Impact factor: 4.818

9.  A validated mouse model capable of recapitulating the protective effects of female sex hormones on ascending aortic aneurysms and dissections (AADs).

Authors:  Xiaoyan Qi; Fen Wang; Changzoon Chun; Lennon Saldarriaga; Zhisheng Jiang; Eric Y Pruitt; George J Arnaoutakis; Gilbert R Upchurch; Zhihua Jiang
Journal:  Physiol Rep       Date:  2020-11

10.  A seX(X/Y) Article on Marfan Syndrome.

Authors:  Nicole K Anderson; Emily E Juzwiak; Harry C Dietz
Journal:  J Am Heart Assoc       Date:  2020-10-16       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.